Magnus Frödin Bolling

Articles

Article: EXPERIMENTAL AND MOLECULAR PATHOLOGY. 2021;122:104667

Nuclear and stromal expression of Manic fringe in renal cell carcinoma.

Cheng WK; Kaur G; Sjöberg E; Frödin M; Egevad L; Harmenberg U; Li J-L; Oon CE
Article: BRITISH JOURNAL OF CANCER. 2018;119(7):840-846

A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis.

Sjöberg E; Frödin M; Lövrot J; Mezheyeuski A; Johansson M; Harmenberg U; Egevad L; Sandström P; Östman A
Article: BRAIN SCIENCES. 2018;8(8):E151-151

Neurite Growth and Polarization on Vitronectin Substrate after in Vitro Trauma is not Enhanced after IGF Treatment.

Bergen K; Frödin M; von Gertten C; Sandberg-Nordqvist A-C; Sköld MK
Article: JOURNAL OF PATHOLOGY CLINICAL RESEARCH. 2017;3(3):214-224

Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker.

Corvigno S; Frödin M; Wisman GBA; Nijman HW; Van der Zee AG; Jirström K; Nodin B; Hrynchyk I; Edler D; Ragnhammar P; Johansson M; Dahlstrand H; Mezheyeuski A; Östman A
Article: BRITISH JOURNAL OF CANCER. 2017;116(2):195-201

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.

Frödin M; Mezheyeuski A; Corvigno S; Harmenberg U; Sandström P; Egevad L; Johansson M; Östman A

Postdoctoral Studies, Department of Oncology-Pathology, Karolinska Institutet, 2022-2024

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2018
University Medical Degree, Karolinska Institutet, 2007